AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 22 min read$AI

Ehikian Stephen Bradley sold $478K of AI

Ehikian Stephen Bradley (Chief Executive Officer) sold 50,542 shares of C3.ai, Inc. (AI) at $9.45 ($0.48M total) on 2026-07-01.

Original reporting
SEC EDGAR · Ehikian Stephen Bradley
Published Jul 2, 2026, 9:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 9:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AI
Neutral
medium confidence
Mentioned
$AI
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AINeutralLow
01

Why it matters

The newest fact is the CEO’s open-market sale size, price, and post-transaction holdings; it can modestly affect sentiment but does not introduce new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a durable repricing without corroborating fundamental news.

03

What to watch

No 10b5-1 plan is stated, but the article provides no reason for the sale, no option exercises, and no linkage to any new C3.ai event.

Relevance 4/10Novelty 5/10Timing: after-hours/next-session read-through from a newly filed Form 4 (filed 2026-07-02)

Background

This is a primary-source SEC Form 4 insider transaction disclosure for C3.ai, Inc. (AI).

Company-level read

Ticker impact

$AINeutralMedium confidence
Context

C3.ai CEO Ehikian Stephen Bradley filed a Form 4 selling 50,542 shares at $9.45 on 2026-07-01.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small versus fundamentals.

Evidence & confidence

The filing is a disclosed sale (S) with no 10b5-1 plan and no accompanying company-specific news (guidance, contract, enforcement).

Market effects

Sector

Minimal; insider-sale filings rarely change sector expectations without additional company-specific developments.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale may be for diversification/taxes rather than bearish expectations, especially given the disclosed post-sale holdings remain substantial.

Key entities

  • issuer
    C3.ai, Inc.

    Subject of the Form 4 insider transaction; CEO sold shares via open-market sale.

  • insider
    Ehikian Stephen Bradley

    CEO who reported the sale of 50,542 shares at $9.45 on 2026-07-01.

Read at source← All news

Related articles

JUL 8
$AIMed

Trump Family Pockets Half A Billion As Trump-Backed Crypto Firm Moves To Sell Only Revenue-Generating Business

The Wall Street Journal reports Nasdaq-listed AI Financial (formerly Alt5 Sigma) is in talks to sell its only revenue-generating payments subsidiary to Tokyo-based Perpetuals.com for up to $15 million. The unit generated about $25 million revenue in 2024. AI Financial’s losses followed World Liberty’s August 2025 WLFI token purchase and WLFI’s ~70% decline, with AI Financial reporting a $271 million quarterly loss.

ibtimes.com6 min
JUN 4
$AIMedAI 9/10

C3.ai Q4 2026 Earnings Call Transcript - C3.ai (NYSE:AI)

C3.ai held its Q4 earnings call, reporting total revenue of $51.6 million, with subscription revenue 94% of the total. The company said it cut headcount about 35% and expects ~$135 million in annual operating cost savings. CEO Tom Siebel cited poor sales execution and plans to expand its target accounts. FY2027 guidance calls for $210–$240 million revenue and non-GAAP operating loss of $128–$160 million.

benzinga.com6 min
JUN 3
$AIHighAI 9/10

Live: Will C3.ai Beat Q4 Earnings After the Bell Tonight?

C3.ai (AI) reports Q4 fiscal 2026 results after the close. The company is focused on revenue within guidance ($48.0M–$52.0M), improving GAAP gross margin from 17% (down from 59% a year earlier), and expanding federal bookings, which rose 134% YoY to 55% of total bookings. Wall Street has 6 sell and 7 hold ratings; average target is $8.82 vs. $10.51.

247wallst.com4 min
MAY 30
$AIMedAI 8/10

Wall Street Has a Consensus on This AI Stock. The Consensus Is Dead Wrong.

The article argues that Wall Street’s consensus on C3.ai (AI) is inconsistent and may not reflect deteriorating fundamentals. It cites a hold consensus from 12 analysts with an average price target near $17 versus a stock price around $9.50. For fiscal Q1 2026 ended July 31, C3.ai reported about $50M revenue, missed guidance, posted a $0.40 loss per share vs $0.30 estimate, and guided continued pressure.

fool.com6 min
MAY 25
$AIMedAI 9/10

Thomas Siebel Is Back as C3.ai CEO. Will This Help the Stock Rebound?

C3.ai shares are down 59% over 12 months as the company’s sales have declined, despite having 100+ enterprise AI turnkey solutions. After CEO/founder Thomas Siebel stepped down in 2024 for health reasons and Stephen Ehikian took over Sept. 1, 2025, C3.ai reported preliminary Q4 revenue of $51.6M vs. $108.7M a year earlier. The company says Siebel returned as CEO May 8.

fool.com3 min